机构:[1]Department of Pharmacology, Guangdong Key Laboratory for Research and Development of Natural Drugs, Guangdong Medical University, Zhanjiang, Guangdong, China[2]Department of Orthopedics and Traumatology, Nanning Hospital of Traditional Chinese Medicine, Guangxi University of Chinese Medicine, Nanning, Guangxi, China[3]Department of Phamacy, Yuebei people’s Hospital, Shaoguan, Guangdong, China[4]Department of Endocrinology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China[5]Xiamen Medical College, Xiamen, Fujian, China[6]Department of Traditional Chinese Medicine, Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong, China南方医科大学深圳医院深圳市康宁医院深圳医学信息中心[7]Department of the Ministry of Science and Technology, Guangxi International Zhuang Medicine Hospital, Nanning, Guangxi 530201, China
Oxidative stress is a promoting factor in the pathologic process of glucocorticoid - induced osteoporosis (GIO), while the mechanism is still unclear. Thioredoxin-interacting protein (TXNIP) is a vital protein responsible for regulation of cellular reactive oxygen species (ROS) generation elicited by mitochondrial oxidative stress, and which may activate oxidative phosphorylation under the pathogenic status. In this research, the results showed that signaling pathway associated with the mitochondrial oxidative phosphorylation (MOP) down-regulated under conditions of TXNIP siRNA in MG63 cells. Furthermore, the evidence revealed that the expression level of TXNIP in serum and bone was elevated in a rat of GIO. Moreover, the differential proteins (Ndufs3, SDHD, Cyt B, COX IV, and ATP B) related to MOP pathway were identified to down-regulate in the proteomics of bone tissues by using isobaric Tags for Relative and Absolute Quantification (iTRAQ) method in TXNIP knockout mice treated with glucocorticoid, and the proteins were also verified by simple western blot. Taken together, the present findings highlights that TXNIP involves in triggering the process of bone loss via up-regulation of the MOP pathway, resulting to GIO, while TXNIP knockout can prevent the pathogenesis of GIO to some extent.
基金:
the National Natural Science Foundation of China (No. 81673814); Science and Technology Planning Project of Guangdong Province of China (No. 2016A020215148, No. 2016B030309002); Medical Scientific Research Foundation of Guangdong Province of China (No. A2016293); Key laboratory of functional and clinical translational medicine, Fujian province university (No. JNYLC1812). Innovation and Practice Base for Postdoctoral Researchers of Guangxi International Zhuang Medicine Hospital
语种:
外文
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2020]版:
大类|3 区医学
小类|3 区医学:研究与实验3 区药学
最新[2025]版:
大类|3 区医学
小类|2 区药学3 区医学:研究与实验
JCR分区:
出版当年[2019]版:
Q2MEDICINE, RESEARCH & EXPERIMENTALQ2PHARMACOLOGY & PHARMACY
最新[2023]版:
Q1MEDICINE, RESEARCH & EXPERIMENTALQ1PHARMACOLOGY & PHARMACY
第一作者机构:[1]Department of Pharmacology, Guangdong Key Laboratory for Research and Development of Natural Drugs, Guangdong Medical University, Zhanjiang, Guangdong, China[2]Department of Orthopedics and Traumatology, Nanning Hospital of Traditional Chinese Medicine, Guangxi University of Chinese Medicine, Nanning, Guangxi, China
共同第一作者:
通讯作者:
通讯机构:[6]Department of Traditional Chinese Medicine, Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong, China[7]Department of the Ministry of Science and Technology, Guangxi International Zhuang Medicine Hospital, Nanning, Guangxi 530201, China
推荐引用方式(GB/T 7714):
Yulin Mo,Wenxiu Lai,Ying Zhong,et al.TXNIP contributes to bone loss via promoting the mitochondrial oxidative phosphorylation during glucocorticoid-induced osteoporosis [J].LIFE SCIENCES.2021,266:doi:10.1016/j.lfs.2020.118938.
APA:
Yulin Mo,Wenxiu Lai,Ying Zhong,Zhuoqing Hu,Meigui You...&Yajun Yang.(2021).TXNIP contributes to bone loss via promoting the mitochondrial oxidative phosphorylation during glucocorticoid-induced osteoporosis .LIFE SCIENCES,266,
MLA:
Yulin Mo,et al."TXNIP contributes to bone loss via promoting the mitochondrial oxidative phosphorylation during glucocorticoid-induced osteoporosis ".LIFE SCIENCES 266.(2021)